Is 'electrosensitivity' real, and what helps people who have it?

What it is. Researchers call it idiopathic environmental intolerance attributed to electromagnetic fields (IEI-EMF): symptoms that people attribute to electrical devices, with no medical explanation found³. In a representative Swiss phone survey of 2,048 people, 5% reported it. The most common complaints were sleep problems (43%) and headaches (34%), mostly blamed on power lines and phone handsets¹.

What blinded testing shows. In provocation studies, volunteers who report sensitivity are exposed to real or sham fields without knowing which. An updated review pooled 46 such studies with 1,175 volunteers and found no robust evidence that fields trigger symptoms³. In a London trial, 60 sensitive people and 60 controls each spent 50 minutes with a 900 MHz mobile phone signal, a plain carrier wave and a sham signal. Headaches rose during exposure whatever the signal, including the sham, and sensitive people believed a signal was on 60% of the time during real exposure and 63% during sham⁵. A review of 29 experiments with objective measures such as heart rate and blood pressure also found no reliable physiological reaction⁶.

Expectation is powerful. When 147 volunteers watched a TV report on the health risks of Wi-Fi and then received a sham Wi-Fi exposure, 54% reported symptoms they attributed to it, and the report increased worry and the sense of being sensitive⁴. This is the nocebo effect: expecting harm can produce real symptoms.

Real symptoms, not imaginary ones. In interviews with 40 self-identified electrosensitive people, symptoms came first and the suspicion about fields came later⁷. People who adopt the label report much worse general health, more depression and more other unexplained syndromes than other people⁸. Their suffering deserves a full medical look.

What helps. Treatment evidence is thin. In a small controlled trial, 10 patients given cognitive behavioural therapy (CBT) within a multidisciplinary programme rated their sensitivity lower than 12 controls six months later⁹. Reviewers warn that a narrow focus on field mechanisms is unlikely to help patients in the long term³.

Official and dissenting views. The World Health Organization says there is little scientific evidence for electromagnetic hypersensitivity and no accepted biological mechanism to explain it¹⁰. A 2021 consensus report disagrees with how the question has been tested. It argues that provocation tests are not valid until the condition is objectively defined, and that nocebo has not been proven¹¹.

For the wider science of wireless radiation, see What the Science Says. For products sold to block fields, see Do EMF-Blocking Products Work?.

Blinded provocation studies. Rubin and colleagues' first systematic review (2005) found 31 experiments testing 725 'electromagnetically hypersensitive' participants. Twenty-four found no evidence of a biophysical hypersensitivity. Seven reported some support, but two of those groups failed to replicate their own results, three results looked like statistical artefacts, and the last two contradicted each other. Meta-analyses found no better ability to detect fields in the hypersensitive group². The 2010 update raised the total to 46 blind or double-blind studies and 1,175 volunteers, again with no robust evidence that fields trigger symptoms but with support for a nocebo effect³.

Objective outcomes. A 2011 review of 29 experiments with objectively measured outcomes found five with significant effects, among them lower heart rate and blood pressure, an altered pupil reflex, reduced visual attention and changed sleep EEG. These were mostly isolated results that other studies failed to replicate, and the sleep EEG changes also appeared in non-sensitive controls⁶.

A representative trial. The London trial (60 sensitive people, 60 controls) used headache severity on a 0-to-100 scale as its main outcome. Headache rose during exposure and eased afterwards, with no strong difference between real and sham signals or between the two groups. Sham exposure alone triggered severe symptoms in some participants⁵.

Nocebo experiment. Witthöft and Rubin randomised 147 people to a TV report on Wi-Fi's health risks (76) or a control film (71), then gave everyone a 15-minute sham Wi-Fi exposure. Overall 82 people (54%) reported symptoms they attributed to it. The report raised worry about fields and, among people with high anxiety, raised symptoms and the likelihood of seeing themselves as sensitive⁴.

Criticism of the evidence. The verdict is not unchallenged. Schmiedchen and colleagues assessed 28 blinded experiments and found limitations in studies with both positive and negative results, most often in participant selection, counterbalancing of exposure order and effectiveness of blinding. Many lacked power calculations. Even so, the methodologically sound studies indicated that an effect of exposure is unlikely, and the authors concluded that any physical effect must be very weak or affect only a few people¹². Belpomme and colleagues argue that provocation tests cannot settle the question because electrohypersensitivity has not first been defined objectively, that negative results therefore do not exclude a role for fields as a trigger, and that nocebo is unproven. They call for biomarker and imaging research¹¹. Their report is a consensus statement that argues for a different research approach and for recognition as a distinct disorder, not a blinded trial.

Who is affected. In a questionnaire study of 52 people sensitive to mobile phones, 19 who also reported electrosensitivity, and 60 controls, the electrosensitive group had greater depression, more health worries and more other unexplained syndromes, although psychiatric diagnoses did not differ between groups⁸. In the interview study, symptoms preceded any suspicion of fields. That sits awkwardly with a purely nocebo origin, although nocebo responses may reinforce the belief later⁷.

Treatment. In a small controlled CBT trial, 10 treated patients were compared with 12 controls. The treated group rated their electric sensitivity lower at six months, while symptom indices fell over time in both groups and biochemical stress markers did not change⁹. The trial was small and not randomised, so it can only suggest a benefit.

Bottom line (confidence 4). Several systematic reviews of dozens of blinded studies agree: people with electrosensitivity cannot be shown to detect fields, and their symptoms do not reliably follow real exposure. The symptoms themselves are real and sometimes disabling. What causes them is unresolved, and expectation, stress, sleep problems and other illness are all plausible contributors. Trial evidence on treatment is small, and critics of the testing methods deserve a hearing.